GPNMB has also been demonstrated to be neuroprotective in an animal model of amyotrophic lateral sclerosis, cerebral ischemia, and other disease models (Srinivasan et al, 2016; Budge et al, 2018). Here, GPNMB is linked to amyotrophic lateral sclerosis.